683 Capital Management, LLC Bridge Bio Pharma, Inc. Transaction History
683 Capital Management, LLC
- $1.1 Billion
- Q3 2024
A detailed history of 683 Capital Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, 683 Capital Management, LLC holds 550,000 shares of BBIO stock, worth $15.4 Million. This represents 1.27% of its overall portfolio holdings.
Number of Shares
550,000
Previous 200,000
175.0%
Holding current value
$15.4 Million
Previous $5.07 Million
176.41%
% of portfolio
1.27%
Previous 0.46%
Shares
3 transactions
Others Institutions Holding BBIO
# of Institutions
290Shares Held
170MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$707 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$703 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$397 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$348 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$170 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.15B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...